Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Model No: DM 1613220-15-7
Purity: 99%
Appearence: White Crystalline Powder
Kemasan: Seperti yang dipersyaratkan
Produktivitas: Stock available
Transportasi: Ocean,Air,Courier
Tempat asal: Hebei, Cina
Dukungan tentang: As per order
Sertifikat: ISO9001
Pelabuhan: Shanghai,Shenzhen,Hangzhou
Jenis pembayaran: L/C,T/T,D/P,Paypal
Inkoterm: FOB,CIF
Kualitas Tinggi Harga Terbaik Niraparib Tosylate Monohydrate CAS No.1613220-15-7 :
Produk Na M E: Niraparib tosylate monohydrate
Sinonim: MK4827 Tosylate;
(S) -2- (4- (piperidin-3-yl) fenil) -2H-indazole-7-carboxamide 4-methylbenzenesulfonate;
CAS no .: 1613220-15-7 MF: C26H28N4O4S MW: 492.59
Penampilan: bubuk kristal putih atau kekuningan
Kemurnian: 99,0% +
COA: tersedia
Niraparib adalah penghambat PARP molekul kecil yang aktif secara oral yang dikembangkan oleh Tesaro untuk mengobati kanker ovarium.
It is used for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy.Niraparib is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian kanker.
Produksi Intermediate Niraparib kami :
Paket & Pengiriman:
Paket: tas PE ganda dengan tas foil atau sesuai kebutuhan
Waktu Pengiriman: Tersedia Stok
Port: Port apa pun di Cina
Kategori Produk : API dan perantara > Niraparib Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.